StockTipsArenaBeta

BUY IPCA Laboratories Limited — Chandan Taparia, Motilal Oswal

BUYIPCA Laboratories Limited
IPCA Laboratories share price target & all analyst calls

byChandan Taparia, Motilal OswalHorizon: NA (inferred Intraday)3 Jul 2026, 9:50 am ISTvia CNBC Awaaz.

Entry₹1,752.6Inferred
Target₹1,800
Total upside +2.70% (call closed)
Stop loss₹1,705-2.72% risk
At expiry₹1,7783 Jul 2026, 3:20 pm
Expired+1.45%
Follow Chandan Taparia for new calls(13% target hit, 83 closed calls)Get alertsWatch IPCALAB for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 3 Jul 2026
1 supporting0 opposing
Supports the BUY call (1)

IPCA Laboratories Limited's Board approved the Scheme of Amalgamation of Krebs Biochemicals & Industries Ltd. with Ipca Laboratories Ltd. The merger aims for operational synergies, cost optimization,

NSE · Outcome of Board Meeting·26 Jun · 1w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on IPCA Laboratories

All analyst calls on IPCA Laboratories

More from Chandan Taparia, Motilal Oswal

Every call and its outcome